Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-03-08
2011-03-08
Kolker, Daniel E (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S034000, C436S090000
Reexamination Certificate
active
07901895
ABSTRACT:
Methods for screening for neurological disorders are disclosed. Specifically, methods are disclosed for screening for neurological disorders in a subject by analyzing a tissue sample obtained from the subject for the presence of elevated levels of neurotoxic amino acids or neurotoxic derivatives thereof associated with neurological disorders. In particular, methods are disclosed for diagnosing a neurological disorder in a subject, or predicting the likelihood of developing a neurological disorder in a subject, by determining the levels of β-N-methylamino-L-alanine (BMAA) in a tissue sample obtained from the subject. Methods for screening for environmental factors associated with neurological disorders are disclosed. Methods for inhibiting, treating or preventing neurological disorders are disclosed.
REFERENCES:
patent: 5210076 (1993-05-01), Berliner et al.
patent: 5824554 (1998-10-01), McKay
patent: 6043283 (2000-03-01), Giulian
patent: 02/37122 (2002-05-01), None
Bussiere 1999. Acta Neuropathol. 97:221-230.
Rhys Williams et al. 1982 (Analyst 107:109-1094).
Ojanpera 1991 (Analyst 16:265-267).
Alberts et al.Molecular Biology of the Cell. 3rded. New York: Garland Publishing; 1994:49, 56, and 132.
Armon, C. Western Pacific ALS/PDC and flying foxes.NeurologyAug. 2003; 61:291-292.
Banack, 2002. Oral Session #89, Biodiversity and Ecosystem Function III, Ecological Society of America Annual Meeting. Presented Thursday Aug. 8, 2002.
Banack et al. Biomagnification of cycad neurotoxins in flying foxes, Implications for ALS-PDC in Guam.NeurologyAug. 12, 2003; 61(3):387-389.
Banack et al. Distribution of the neurotoxic nonprotein amino acid BMAA inCycas micronesica. Botanical Journal of the Linnean Society2003; 143:165-168.
Bjartmar et al. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.J. Neurol Sci2003; 206:165-171.
Brenner et al. Cycads: evolutionary innovations and the role of plant-derived neurotoxins.Trends in Plant ScienceSep. 2003; 8(9):446-452.
Brownson et al. The cycad neurotoxic amino acid, β-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells.Journal of Ethnopharmacology2002; 82:159-167.
Cassel et al. Demography and Epidemiology of Age-Associated Neuronal Impairment. In: PR Hof and CV Mobbs, eds.Functional Neurobiology of AgingSan Diego: Academic Press. 2000:31-50.
Charlton et al. Quantification of the Neurotoxin 2-Amino-3-(Methylamino)-propanoic acid (BMAA) in Cycadales.Phytochemistry1992; 31(10):3429-3432.
Chen et al. Cycad neurotoxin, consumption of flying foxes, and ALS/PDC disease in Guam and author reply.NeurologyNov. 26, 2002; 59 (10):1664-1665.
Cluskey et al. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis.Mol Pathol2001; 54:386-392.
Cox et al. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.PNAS(USA) Nov. 11, 2003; 100(23):13380-13383.
Cox et al. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam.NeurologyMar. 26, 2002; 58(6):956-959.
Deumens et al. Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway.Experimental Neurology2002; 175:303-317.
Duncan et al. 2-Amino-3-(methylamino) propanoic acid (BMAA) Bioavailability in the Primate.Neurobiology of Aging1992; 13(2):333-337.
Duncan et al. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: An unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.NeurologyMay 1990; 40(5):767-772.
Duncan et al. 2-Amino-3-(methylamino)-propanoic acid (BMAA) Pharmacokinetics and Blood-Brain Barrier Permeability in the Rat.The Journal of Pharmacology and Experimental Therapeutics1991; 258(1):27-35.
Duncan et al. Quantification of the Putative Neurotoxin 2-Amino-3-(methylamino)propanoic Acid (BMAA) in Cycadales: Analysis of the Seeds of Some Members of the Family Cycadaceae.Journal of Analytical ToxicologyMay/Jun. 1989; 13(3):169-175.
Duncan et al. Zinc, a Neurotoxin to Cultured Neurons, Contaminates Cycad Flour Prepared by Traditional Guamanian Methods.The Journal of NeuroscienceApr. 1992; 12(4):1523-1537.
Ellison et al. A Postmortem Study of Amino Acid Neurotransmitters in Alzheimer's Disease.Ann Neurol1986; 20:616-621.
Forman et al. Tau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam.American Journal of PathologyMay 2002; 160(5):1725-1731.
Furey et al. The first identification of the rare cyanobacterial toxin, homoanatoxin-a, in Ireland.Toxicon2003; 41:297-303.
Giannakopoulos et al. Types of Age-Related Brain Lesions and Relationship to Neuropathologic Diagnostic Systems of Alzheimer's Disease. In: PR Hof and CV Mobbs, eds.Functional Neurobiology of Aging. San Diego:Academic Press; 2000: 65-76.
Haider et al. Cyanobacterial toxins: a growing environmental concern.Chemosphere2003; 52:1-21.
Hampton, Food Chain of Evidence Points to Brain Toxin.JAMADec. 3, 2003; 290(21):2788-2789.
Harvey et al. Memory Changes with Aging and Dementia, In: PR Hof and CV Mobbs, eds.Functional Neurobiology of Aging. San Diego:Academic Press; 2000:53-63.
Hoffner et al. Protein aggregation in Huntington's disease.Biochimie84 (2002) pp. 273-278.
Kandel et al.Principles of Neural Science, 3rded. New York: Elsevier; 1991:980.
Kisby et al. Content of the neurotoxins cycasin (methylazoxymethanol β-D-glucoside) and BMAA (β-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros.Neurology1992; 42(7):1336-1340.
Kisby et al. Cycasin and BMAA: Candidate Neurotoxins for Western Pacific Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex.Neurodegeneration1992; 1(1):73-82.
Kisby et al. Determination of β-N-methylamino-L-alanine (BMAA) in plant (Cycas circinalisL.) and animal tissue by precolumn derivatization with 9-fluorenylmethyl chloroformate (FMOC) and reversed-phase high-performance liquid chromatography.Journal of Neuroscience Methods1988; 26(1):45-54.
Lewin, R., Environmental Hypothesis for Brain Diseases Strengthened by New Data.Science1987; 237:483-484.
Martinez, et al. Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia.J Neural Transm Park Dis Dement Sect1993; 6:1-9.
Monson et al. Conservation Implications of Chamorro Consumption of Flying Foxes as a Possible Cause of Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex in Guam.Conservation BiologyJun. 2003; 17(3):678-686.
Myers et al. Neuroactive Carbamate Adducts of β-N-Methylamino-L-alanine and Ethylenediamine.J Biol ChemJun. 1990; 265(18):10193-10195.
Oh et al. Screening for Non-Protein Amino Acids in Seeds of the Guam Cycad,Cycas circinalis, by an Improved GC-MS Method.Planta Med1995; 61(1):66-70.
Pai et al. Billionfold difference in the toxic potencies of two excitatory plant amino acids, L-BOAA and L-BMAA: biochemical morphological studies using mouse brain slices.Neuroscience Research1993; 17:241-248.
Pan et al. Identification of nonprotein amino acids from cycad seeds as N-ethoxycarbonyl ethyl ester derivatives by positive chemical-ionization gas chromatography-mass spectrometry.Journal of Chromatography A1997; 787:288-294.
Perry et al. Amyotrophic Lateral Sclerosis: Amino Acid Levels in Plasma and Cerebrospinal Fluid.Ann Neurol1990:28:12-17.
Schmidt et al. Amyloid plaques in Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex contain species of Aβ similar to those found in the amyloid plaques of Alzheimer's disease and pathological aging.Acta Neuropathol1998; 95:117-122.
Slides from presentation in Honolulu, Hawaii, Dec. 9, 2002, entitled: Island Peoples and Human Health: An Ethnobotanical Approach.
Slides from presentation in Stockholm, Sweden, Jun. 2003, entitled: Biomagnification of Neurotoxins and ALS-PDC in Guam.
Slides from presentation to the Plant Biotechnology and Molecular Biology Program, Colorado State University, Fort Collins, CO, Mar. 2003, entitled: New Drugs from Old Plants.
Slides from presentation to the Trustees of the Edinbu
Banack Sandra
Cox Paul A
Murch Susan
Kolker Daniel E
Pillsbury Winthrop Shaw & Pittman LLP
The Institute for Ethnomedicine
LandOfFree
Screening for neurotoxic amino acid associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening for neurotoxic amino acid associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening for neurotoxic amino acid associated with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2729225